Literature DB >> 26893009

[Body dysmorphic disorder : Anxiety about deformity].

T Gieler1,2, E Brähler3,4.   

Abstract

Between 0.8 and 1.8 % of the German population suffers from a body dysmorphic disorder. In specific settings like dermatological offices up to 11.9 % of patients suffer from this disease. The highest prevalence could be found in the field of cosmetic dermatology with a prevalence of 13.1 %. Until now, the diagnosis has been made too rarely. The body dysmorphic disorder is a chronic psychic disease, in which the patients feel disfigured and experience shame and disgust at the same time. Comorbidities like social phobia, depression, suicidality, and eating disorders are frequent. The diagnosis is made using questionnaires (e.g., dysmorphic concern questionnaire) or by use of the DSM-5 manual. An early diagnosis seems to be important to avoid chronification and suicidal ideas. Therapeutic approaches should include cognitive behavioral therapies as well as the use of SSRIs.

Entities:  

Keywords:  Body image; Body scheme; Cognitive behavior therapy; Dermatology; Psychodynamic psychotherapy

Mesh:

Substances:

Year:  2016        PMID: 26893009     DOI: 10.1007/s00105-016-3762-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  37 in total

1.  A 12-month follow-up study of the course of body dysmorphic disorder.

Authors:  Katharine A Phillips; Maria E Pagano; William Menard; Robert L Stout
Journal:  Am J Psychiatry       Date:  2006-05       Impact factor: 18.112

2.  Dysmorphobia group treatment.

Authors:  A Bystritsky; T Vapnik
Journal:  Depress Anxiety       Date:  1997       Impact factor: 6.505

3.  Classification of body dysmorphic disorder - what is the advantage of the new DSM-5 criteria?

Authors:  Katharina Schieber; Ines Kollei; Martina de Zwaan; Alexandra Martin
Journal:  J Psychosom Res       Date:  2015-01-09       Impact factor: 3.006

4.  A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.

Authors:  S Saxena; A Winograd; J J Dunkin; K Maidment; R Rosen; T Vapnik; G Tarlow; A Bystritsky
Journal:  J Clin Psychiatry       Date:  2001-01       Impact factor: 4.384

5.  Modular cognitive-behavioral therapy for body dysmorphic disorder.

Authors:  Sabine Wilhelm; Katharine A Phillips; Jeanne M Fama; Jennifer L Greenberg; Gail Steketee
Journal:  Behav Ther       Date:  2011-05-01

6.  Thirty-three cases of body dysmorphic disorder in children and adolescents.

Authors:  R S Albertini; K A Phillips
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-04       Impact factor: 8.829

7.  Metacognitive therapy for body dysmorphic disorder patients in Iran: acceptability and proof of concept.

Authors:  Mehdi Rabiei; Sandra Mulkens; Mehrdad Kalantari; Hossein Molavi; Fatemeh Bahrami
Journal:  J Behav Ther Exp Psychiatry       Date:  2011-10-04

8.  The prevalence of body dysmorphic disorder: a population-based survey.

Authors:  Winfried Rief; Ulrike Buhlmann; Sabine Wilhelm; Ada Borkenhagen; Elmar Brähler
Journal:  Psychol Med       Date:  2006-03-06       Impact factor: 7.723

9.  Shadows of Beauty - Prevalence of Body Dysmorphic Concerns in Germany is Increasing: Data from Two Representative Samples from 2002 and 2013.

Authors:  Tanja Gieler; Gabriele Schmutzer; Elmar Braehler; Christina Schut; Eva Peters; Jörg Kupfer
Journal:  Acta Derm Venereol       Date:  2016-08-23       Impact factor: 4.437

10.  Suicidality in body dysmorphic disorder: a prospective study.

Authors:  Katharine A Phillips; William Menard
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242

View more
  2 in total

1.  Narrative: The Fear of Disfigurement in Cancer Patients.

Authors:  Aruna Deshpande; Ravindra Ghooi
Journal:  Indian J Palliat Care       Date:  2017 Jul-Sep

2.  Body dysmorphic disorder of female genitalia: a qualitative study of Swiss obstetrician-gynecologists' experiences and practices.

Authors:  Olenka Dworakowski; Marie Drüge; Michelle Schlunegger; Birgit Watzke
Journal:  Arch Gynecol Obstet       Date:  2021-09-30       Impact factor: 2.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.